Blome James 4
4 · Calyxt, Inc. · Filed Jul 2, 2019
Insider Transaction Report
Form 4
Calyxt, Inc.CLXT
Blome James
Chief Executive Officer
Transactions
- Award
Stock Option (Right-to-Buy)
2019-06-28+125,000→ 125,000 totalExercise: $12.48From: 2020-06-28Exp: 2029-06-28→ Common Stock (125,000 underlying) - Award
Performance Stock Units
2019-06-28+166,667→ 166,667 totalExp: 2022-06-28→ Common Stock (166,667 underlying) - Award
Common Stock
2019-06-28+50,000→ 204,136 total
Footnotes (3)
- [F1]50,000 Restricted Stock Units with respect to Calyxt, Inc. common stock were granted to reporting person on 6/28/2019 and vest as to 15% of the underlying shares on the first anniversary of the Grant Date, as to 10% of the underlying shares on the second anniversary of the Grant Date, and as to 5% of the underlying shares on the last day of each calendar quarter beginning on the first full calendar quarter after the second anniversary of the Grant Date.
- [F2]Stock Option vests as to 15% of the underlying shares on the first anniversary of the Grant Date, as to 10% of the underlying shares on the second anniversary of the Grant Date, and as to 5% of the underlying shares on the last day of each calendar quarter beginning the first full calendar quarter after the second anniversary of the Grant Date.
- [F3]Each performance stock unit (PSU) represents a contingent right to receive one share of Calyxt common stock. The PSU will vest as to 50%, 100% or 120% of the shares at the end of a three year performance period based upon increases in Calyxt common stock from the starting price of $12.48 (and on a linear basis between vesting percentages) and if vested, will be issued as restricted stock with restrictions lapsing on the two year anniversary of the date of issuance.